Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/46875
Title: The impact of hypo-attenuated leaflet thickening on haemodynamic valve deterioration following transcatheter aortic valve replacement.
Authors: Rashid H.N.;Michail M.;Ramnarain J.;Nasis A. ;Nicholls S.J.;Cameron J.D.;Gooley R.P.
Monash Health Department(s): Cardiology (MonashHeart)
Respiratory and Sleep Medicine
Institution: (Rashid, Ramnarain, Nasis, Nicholls, Cameron, Gooley) Monash Heart, Monash Health and Monash Cardiovascular Research Centre, Monash University, Australia
(Michail) Sussex Cardiac Centre, University Hospital Sussex NHS Trust, Brighton, United Kingdom
Issue Date: 6-Mar-2022
Publisher: Elsevier Inc.
Place of publication: United States
Publication information: Journal of Cardiovascular Computed Tomography. 16(2) (pp 168-173), 2022. Date of Publication: 01 Mar 2022.
Journal: Journal of Cardiovascular Computed Tomography
Abstract: Background: Hypo-attenuated leaflet thickening (HALT) may occur following transcatheter aortic valve replacement (TAVR), however, it remains unclear if HALT is a predictor of haemodynamic valve deterioration (HVD). Aim(s): To determine the impact of HALT on the occurrence of HVD. Method(s): We prospectively evaluated 186 patients for the presence of HALT at a median of 6 weeks following TAVR (Interquartile-range [IQR] 4-12 weeks). HALT depth and area were measured. HVD encompassed any of the following: mean gradient >=20 mmHg with an increase in gradient >=10 mmHg from baseline, Doppler velocity index reduction >=0.1 or new moderate-to-severe valvular regurgitation. Routine echocardiograms at discharge, one month and annually, were assessed by echo-cardiologists that were blinded to the HALT status. Result(s): LT prevalence was 17.7% (33/186). HVD was present in 8.6% (16/186) at a median follow-up of 2 years (IQR 1-3); two required valve re-intervention and five required anticoagulation. HALT was the only independent predictor of HVD on multivariate analysis (OR 33.3, 95%CI 7.4-125). Patients with HALT were more likely to develop HVD, require repeat valve intervention and have higher trans-valvular gradients at up to 3-year follow-up. Patients with HALT had a median cumulative thickness of 2.9 mm (IQR 1.9-4.7) and area of 64.2 mm2 (IQR 40.9-91.6). Thresholds for HALT in predicting HVD were a cumulative depth of 2.4 mm (Specificity 94.1%, Sensitivity 75.0%, AUC = 0.87) and cumulative area of 28 mm2 (Specificity 92.2%, Sensitivity 81.3%, AUC = 0.86). Conclusion(s): HALT is an independent predictor of HVD, which exhibits specific depth and area thresholds to predict HVD. CT following TAVR may determine patients at risk of HVD.Copyright © 2021
DOI: http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1016/j.jcct.2021.11.013
PubMed URL: 34852974 [https://www.ncbi.nlm.nih.gov/pubmed/?term=34852974]
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/46875
Type: Article
Subjects: aged
anticoagulant therapy
body mass
cerebrovascular accident
chronic obstructive lung disease
computer assisted tomography
coronary artery bypass graft
echocardiography
four dimensional computed tomography
heart cycle
heart failure
percutaneous coronary intervention
practice guideline
surface property
transcatheter aortic valve implantation
transient ischemic attack
valve deterioration/co acetylsalicylic acid/pv [Special Situation for Pharmacovigilance]
clopidogrel/pv [Special Situation for Pharmacovigilance]
heparin/ia [Intraarterial Drug Administration]
heparin/pv [Special Situation for Pharmacovigilance]
iohexol/pv [Special Situation for Pharmacovigilance]
protamine/pv [Special Situation for Pharmacovigilance]
aortic valve prosthesis
computed tomography scanner
heart valve bioprosthesis
percutaneous aortic valve
percutaneous aortic valve bioprosthesis
haemodynamic valve deterioration/co hypoattenuated leaflet thickening/co CoreValve/Evolut
Appears in Collections:Articles

Show full item record

Page view(s)

16
checked on Nov 24, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.